An Immunoreceptor-Targeting Strategy with Minimalistic C3b Peptide Fusion Enhances SARS-CoV-2 RBD mRNA Vaccine ...
Introduction Global efforts to contain the COVID-19 pandemic has brought forth development of novel diagnostic methods and vaccine strategies.1–3 In particular, clinical approval of the first mRNA vaccine, BNT162b from Pfizer/BioNTech, highlights …